4-butyrolactone has been researched along with Chagas Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaral, M; Andrade, CH; Antar, GM; Conserva, GAA; da Costa-Silva, TA; Lago, JHG; Neves, BJ; Tempone, AG | 1 |
| Bastos, JK; da Silva Ferreira, D; de Albuquerque, S; de Gaitani, CM; E Silva, ML; Esperandim, VR; Ferraudo, AS; Lira, AA; Marchetti, JM; Saraiva, J | 1 |
| Bastos, JK; Costa, ES; da Silva Ferreira, D; de Albuquerque, S; Esperandim, VR; Pereira, AC; Saraiva, J; Silva, ML | 1 |
| Andrade E Silva, ML; Bastos, JK; Cunha, WR; da Silva Ferreira, D; de Albuquerque, S; Esperandim, VR; Saraiva, J; Sousa Rezende, KC | 1 |
| Barbosa, LC; de Camargo, MS; de Souza Rezende, KC; E Silva, ML; Resende, FA; Tavares, DC; Varanda, EA | 1 |
| Bastos, JK; Cunha, WR; da Silva Ferreira, D; de Albuquerque, S; e Silva, ML; Esperandim, VR; Rezende, KC; Saraiva, J | 1 |
| Albuquerque, S; Bastos, JK; da Silva Filho, AA; da Silva, R; de Souza, GH; de Souza, VA; Donate, PM; e Silva, ML; Grando, MD; Montanheiro, M; Pereira, AC; Royo, Vde A; Saraiva, J | 1 |
7 other study(ies) available for 4-butyrolactone and Chagas Disease
| Article | Year |
|---|---|
Butenolides from Nectandra oppositifolia (Lauraceae) displayed anti-Trypanosoma cruzi activity via deregulation of mitochondria.
Topics: 4-Butyrolactone; Animals; Brazil; Cell Membrane; Chagas Disease; Humans; Lauraceae; Membrane Potential, Mitochondrial; Mitochondria; Trypanocidal Agents; Trypanosoma cruzi | 2019 |
(-)-Hinokinin-loaded poly(D,-lactide-co-glycolide) microparticles for Chagas disease.
Topics: 4-Butyrolactone; Animals; Antiprotozoal Agents; Benzodioxoles; Chagas Disease; Delayed-Action Preparations; Dioxanes; Dioxoles; Disease Models, Animal; Humans; Lactic Acid; Lignans; Mice; Microspheres; Parasitemia; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Treatment Outcome; Trypanosoma cruzi | 2010 |
Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones.
Topics: 4-Butyrolactone; Animals; Benzodioxoles; beta-Galactosidase; Chagas Disease; Chronic Disease; Dioxoles; Heart; Karyometry; Lactones; Lignans; Liver; Mice; Mice, Inbred BALB C; Spleen; Treatment Outcome; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
In vivo infection by Trypanosoma cruzi: a morphometric study of tissue changes in mice.
Topics: 4-Butyrolactone; Animals; Antiprotozoal Agents; Benzodioxoles; Biometry; Cell Line; Chagas Disease; Dioxoles; Disease Models, Animal; Fibroblasts; Karyotyping; Lignans; Liver; Macaca mulatta; Male; Mice; Mice, Inbred BALB C; Spleen; Trypanosoma cruzi | 2013 |
Mutagenicity and antimutagenicity of (-)-hinokinin a trypanosomicidal compound measured by Salmonella microsome and comet assays.
Topics: 4-Butyrolactone; Animals; Antimutagenic Agents; Benzodioxoles; Cell Line; Chagas Disease; Comet Assay; Cricetinae; Dioxoles; DNA Damage; Humans; Lignans; Mutagens; Piper; Plant Extracts; Salmonella; Seeds; Trypanocidal Agents | 2012 |
Evaluation of the in vivo therapeutic properties of (-)-cubebin and (-)-hinokinin against Trypanosoma cruzi.
Topics: 4-Butyrolactone; Animals; Benzodioxoles; Chagas Disease; Dioxoles; Lignans; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Piper; Trypanocidal Agents; Trypanosoma cruzi | 2013 |
Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.
Topics: 4-Butyrolactone; Animals; Benzodioxoles; Chagas Disease; Inhibitory Concentration 50; Lignans; Membrane Glycoproteins; Parasitic Sensitivity Tests; Protozoan Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2005 |